Srikanth C. Nallani

1.5k total citations
17 papers, 877 citations indexed

About

Srikanth C. Nallani is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Srikanth C. Nallani has authored 17 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 8 papers in Pharmacology and 3 papers in Anesthesiology and Pain Medicine. Recurrent topics in Srikanth C. Nallani's work include Pharmacogenetics and Drug Metabolism (8 papers), Opioid Use Disorder Treatment (6 papers) and Pregnancy and Medication Impact (4 papers). Srikanth C. Nallani is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Opioid Use Disorder Treatment (6 papers) and Pregnancy and Medication Impact (4 papers). Srikanth C. Nallani collaborates with scholars based in United States, United Kingdom and Netherlands. Srikanth C. Nallani's co-authors include Elinore F. McCance‐Katz, Lynn E. Sullivan, Pankaj B. Desai, Donna J. Buckley, Arthur R. Buckley, Rucha Sane, Niresh Hariparsad, Ping Zhao, Alice Ke and Amin Rostami‐Hodjegan and has published in prestigious journals such as Epilepsia, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

Srikanth C. Nallani

14 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Srikanth C. Nallani United States	11	302	279	241	189	133	17	877
Martine Monnat Switzerland	11	151 0.5×	230 0.8×	176 0.7×	107 0.6×	86 0.6×	23	697
Johanna Sistonen Finland	18	98 0.3×	728 2.6×	300 1.2×	345 1.8×	52 0.4×	34	1.3k
Elizabeth Ludwig United States	19	98 0.3×	208 0.7×	173 0.7×	119 0.6×	117 0.9×	59	1.1k
Tatiana Nanovskaya United States	24	620 2.1×	172 0.6×	796 3.3×	309 1.6×	53 0.4×	74	1.6k
Aniwaa Owusu Obeng United States	14	156 0.5×	492 1.8×	304 1.3×	87 0.5×	235 1.8×	23	1.1k
Pyry A. J. Välitalo Netherlands	18	85 0.3×	161 0.6×	355 1.5×	130 0.7×	48 0.4×	33	860
Gregory L. Kearns United States	13	50 0.2×	265 0.9×	314 1.3×	106 0.6×	51 0.4×	19	838
George W. Mihaly Australia	24	150 0.5×	407 1.5×	307 1.3×	456 2.4×	45 0.3×	63	1.4k
Stefan Viktor Vormfelde Germany	17	89 0.3×	131 0.5×	171 0.7×	247 1.3×	28 0.2×	37	907
EJ Begg New Zealand	13	117 0.4×	93 0.3×	214 0.9×	158 0.8×	66 0.5×	19	851

Countries citing papers authored by Srikanth C. Nallani

Since Specialization

Citations

This map shows the geographic impact of Srikanth C. Nallani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srikanth C. Nallani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srikanth C. Nallani more than expected).

Fields of papers citing papers by Srikanth C. Nallani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srikanth C. Nallani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srikanth C. Nallani. The network helps show where Srikanth C. Nallani may publish in the future.

Co-authorship network of co-authors of Srikanth C. Nallani

This figure shows the co-authorship network connecting the top 25 collaborators of Srikanth C. Nallani. A scholar is included among the top collaborators of Srikanth C. Nallani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srikanth C. Nallani. Srikanth C. Nallani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Nallani, Srikanth C., et al.. (2025). Toward Developing Alternative Opioid Antagonists for Treating Community Overdose: A Model‐Based Evaluation of Important Pharmacological Attributes. Clinical Pharmacology & Therapeutics. 117(3). 836–845.

Strauss, David G., Zhihua Li, Srikanth C. Nallani, et al.. (2024). Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose. JAMA Network Open. 7(1). e2351839–e2351839. 7 indexed citations

Nallani, Srikanth C., Zhihua Li, Jeffry Florian, et al.. (2024). FDA Approval Summary: Nalmefene Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose. Clinical Pharmacology & Therapeutics. 117(3). 620–626.

Nallani, Srikanth C., et al.. (2023). Clinical Lactation Studies of Neuropsychiatric Medications: Clinical Pharmacology and Labeling Considerations. The Journal of Clinical Pharmacology. 63(S1). S159–S169.

Zhao, Liang, Zhichuan Li, Lanyan Fang, et al.. (2021). Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidance. EClinicalMedicine. 41. 101135–101135. 3 indexed citations

Nallani, Srikanth C., Wenjing Li, Silvia N. Calderon, et al.. (2021). Concentration-Response Model of Immediate Release Oxycodone Drug Liking by Different Routes of Abuse. Pain Medicine. 23(7). 1311–1322. 1 indexed citations

Ke, Alice, Srikanth C. Nallani, Ping Zhao, et al.. (2013). A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women. Drug Metabolism and Disposition. 41(4). 801–813. 71 indexed citations

Ke, Alice, Srikanth C. Nallani, Ping Zhao, Amin Rostami‐Hodjegan, & Jashvant D. Unadkat. (2013). Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19. British Journal of Clinical Pharmacology. 77(3). 554–570. 82 indexed citations

Florian, Jeff, Christine Garnett, Srikanth C. Nallani, Bob A. Rappaport, & Douglas C. Throckmorton. (2012). A Modeling and Simulation Approach to Characterize Methadone QT Prolongation Using Pooled Data From Five Clinical Trials in MMT Patients. Clinical Pharmacology & Therapeutics. 91(4). 666–672. 37 indexed citations

10.

Haas, David M., Beverly Gallauresi, Kristine E. Shields, et al.. (2011). Pharmacotherapy and Pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clinical and Translational Science. 4(3). 204–209. 23 indexed citations

11.

McCance‐Katz, Elinore F., Lynn E. Sullivan, & Srikanth C. Nallani. (2009). Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review. American Journal on Addictions. 19(1). 4–16. 242 indexed citations

12.

Sane, Rucha, Donna J. Buckley, Arthur R. Buckley, Srikanth C. Nallani, & Pankaj B. Desai. (2008). Role of Human Pregnane X Receptor in Tamoxifen- and 4-Hydroxytamoxifen-Mediated CYP3A4 Induction in Primary Human Hepatocytes and LS174T Cells. Drug Metabolism and Disposition. 36(5). 946–954. 23 indexed citations

13.

Hariparsad, Niresh, Srikanth C. Nallani, Rucha Sane, et al.. (2004). Induction of CYP3A4 by Efavirenz in Primary Human Hepatocytes: Comparison With Rifampin and Phenobarbital. The Journal of Clinical Pharmacology. 44(11). 1273–1281. 160 indexed citations

14.

Nallani, Srikanth C., Tracy A. Glauser, Niresh Hariparsad, et al.. (2003). Dose‐dependent Induction of Cytochrome P450 (CYP) 3A4 and Activation of Pregnane X Receptor by Topiramate. Epilepsia. 44(12). 1521–1528. 57 indexed citations

15.

Nallani, Srikanth C., Bryan Goodwin, Jodi M. Maglich, et al.. (2003). Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor. Drug Metabolism and Disposition. 31(5). 681–684. 41 indexed citations

16.

Desai, Pankaj B., Srikanth C. Nallani, Rucha Sane, et al.. (2002). Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen. Drug Metabolism and Disposition. 30(5). 608–612. 106 indexed citations

17.

Nallani, Srikanth C., Mary Beth Genter, & Pankaj B. Desai. (2001). Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel. Cancer Chemotherapy and Pharmacology. 48(2). 115–122. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact